Adriana Ruiz
Medical · Atlanta, GANPI 1386997039
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sequel Med Tech, LLC accounts for 60.1% of it on its own, with 45 other manufacturers making up the rest. 2025 is the largest year on record at $26,155, 9.4 times the $2,796 reported in 2021. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 633 payments — averaging $61.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sequel Med Tech, LLC$23K
- Novo Nordisk$3K
- Amgen$1K
- Lilly USA, LLC$1K
- Corcept Therapeutics$1K
- Sanofi-aventis U.S. LLC$814
- plus $8K from 40 others
What the payments were for
- Consulting fees$17,08444%
- Travel & lodging$5,13713%
- Food & beverage$16,25642%
- Education$1510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TWIIST$22,764
- TEPEZZA$498
- Ozempic$473
- Korlym$429
- Omnipod$320
- MYCAPSSA$261
- RETEVMO$213
- MINIMED 780G$186
- ZENPEP$130
- Kerendia$125
- Wegovy$125
- EVENITY$125
- FARXIGA$125
- NURTEC ODT$124
- RYBELSUS$121
- MOUNJARO$115
- DEXCOM G6 TRANSMITTER$114
- t:slim X2 Insulin Pump with Control-IQ$110
How this compares
$38,626 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 17 | $1,152,444 |
| OzempicSemaglutide | 241 | $367,818 |
| JardianceEmpagliflozin | 79 | $103,804 |
| MounjaroTirzepatide | 41 | $78,401 |
| FarxigaDapagliflozin Propanediol | 39 | $47,170 |
| Tresiba Flextouch U-100Insulin Degludec | 51 | $28,051 |
| JanuviaSitagliptin Phosphate | 14 | $18,051 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $17,990 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 15 | $15,317 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 119 | $14,716 |
| AfrezzaInsulin Regular, Human | 11 | $14,353 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $13,886 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 76 | $11,208 |
| NovologInsulin Aspart | 26 | $7,540 |
| Humalog Kwikpen U-100Insulin Lispro | 26 | $6,195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Corcept TherapeuticsKorlym | $1,233 | $1,152,44417 claims |
| Novo NordiskOzempic, Novolog | $2,621 | $375,357267 claims |
| Boehringer IngelheimJardiance | $397 | $103,80479 claims |
| Lilly USA, LLCMounjaro | $1,389 | $78,40141 claims |
| AstraZenecaFarxiga | $414 | $47,17039 claims |
| MerckJanuvia | $41 | $18,05114 claims |
| Mannkind CorporationAfrezza | $626 | $14,35311 claims |
| AbbVieSynthroid | $45 | $1,79113 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $554 | $67372 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 950 medical providers in Georgia.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Danna Dennis-CalderAtlanta$87K
- Ferrina ShethAtlanta$49K
- Punam PunjaAtlanta$31K
- Adrienne AndersonAtlanta$25K
- Jeremiah RobinsonAtlanta$23K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
- Katherine QuinleyAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.